Rhydburg Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 03-07-2024
- Paid Up Capital ₹ 3.70 Cr
as on 03-07-2024
- Company Age 37 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.50 Cr
as on 03-07-2024
- Satisfied Charges ₹ 39.60 Cr
as on 03-07-2024
- Revenue -8.47%
(FY 2023)
- Profit 18.80%
(FY 2023)
- Ebitda 272.01%
(FY 2023)
- Net Worth 3.40%
(FY 2023)
- Total Assets -0.11%
(FY 2023)
About Rhydburg Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.70 Cr.
The company currently has active open charges totaling ₹8.50 Cr. The company has closed loans amounting to ₹39.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashok Monga, Vinod Thapar, and Seema Monga serve as directors at the Company.
- CIN/LLPIN
U24231DL1987PLC028434
- Company No.
028434
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Jun 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rhydburg Pharmaceuticals Ltd offer?
Rhydburg Pharmaceuticals Ltd offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets.
Who are the key members and board of directors at Rhydburg Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Monga  | Whole-Time Director | 15-Dec-1993 | Current |
| Vinod Thapar | Director | 22-Feb-2018 | Current |
| Seema Monga | Whole-Time Director | 01-Sep-2003 | Current |
Financial Performance and Corporate Structure Insights of Rhydburg Pharmaceuticals.
Rhydburg Pharmaceuticals Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.47% decrease. The company also saw a substantial improvement in profitability, with a 18.8% increase in profit. The company's net worth moved up by a moderate rise of 3.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rhydburg Pharmaceuticals?
In 2022, Rhydburg Pharmaceuticals had a promoter holding of 99.35% and a public holding of 0.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Seema Monga's Curls And Curves Llp
Active
9 years 5 months Ashok Monga and Seema Monga are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 04 Sep 2019 | ₹8.50 Cr | Open |
Axis Bank Limited Creation Date: 20 Jul 2020 | ₹4.50 M | Satisfied |
Hdfc Bank Limited Creation Date: 22 Feb 2018 | ₹9.40 Cr | Satisfied |
How Many Employees Work at Rhydburg Pharmaceuticals?
Rhydburg Pharmaceuticals has a workforce of 188 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Aug 30, 2010, Rhydburg Pharmaceuticals has raised a total of ₹ 2.3 M, with the most recent deal valued at ₹ 2 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
